Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy

por Valdecantos, M. Pilar, Ruiz, Laura, Pardo, Virginia, Castro-Sanchez, Luis, García-Monzón, Carmelo, Lanzón, Borja, Rupérez, Javier, Barbas, Coral, Naylor, Jaqueline, Trevaskis, James L., Grimsby, Joseph, Rondinone, Cristina M., Valverde, Ángela M.
Publicado 2018

Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity

por Lanzon, Borja, Martin-Taboada, Marina, Castro-Alves, Victor, Vila-Bedmar, Rocio, González de Pablos, Ignacio, Duberg, Daniel, Gomez, Pilar, Rodriguez, Elias, Orešič, Matej, Hyötyläinen, Tuulia, Morales, Enrique, Ruperez, Francisco J., Medina-Gomez, Gema
Publicado 2021

Renoprotective role of bariatric surgery in patients with established chronic kidney disease

por Morales, Enrique, Porrini, Esteban, Martin-Taboada, Marina, Luis-Lima, Sergio, Vila-Bedmar, Rocío, González de Pablos, Ignacio, Gómez, Pilar, Rodríguez, Elías, Torres, Lucia, Lanzón, Borja, Rodríguez, Ana Elena, Maíz, María, Medina-Gómez, Gema, Praga, Manuel
Publicado 2020

Transforming growth factor β3 deficiency promotes defective lipid metabolism and fibrosis in murine kidney

por Escasany, Elia, Lanzón, Borja, García-Carrasco, Almudena, Izquierdo-Lahuerta, Adriana, Torres, Lucía, Corrales, Patricia, Rodríguez Rodríguez, Ana Elena, Luis-Lima, Sergio, Martínez Álvarez, Concepción, Javier Ruperez, Francisco, Ros, Manuel, Porrini, Esteban, Rydén, Mikael, Medina-Gómez, Gema
Publicado 2021